Search research articles
Contact Us
Filters
Showing results (1-10 of 166) with videos related to
Page
of 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
May 7, 2013
In reply to Fekete
Anders Jakobsen
Expert Review of Anticancer Therapy
|
April 21, 2011
Combining biological agents and chemotherapy in the treatment of cholangiocarcinoma
Lars Henrik Jensen, Anders Jakobsen
Biomarkers in Medicine
|
April 7, 2020
Circulating tumor-specific DNA: a stony road to clinical utility
Caroline B Thomsen, Anders Jakobsen
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 17, 2016
Screening for circulating RAS/RAF mutations by multiplex digital PCR
Rikke Fredslund Andersen, Anders Jakobsen
Medical Physics
|
October 7, 2006
The importance of applicator design for intraluminal brachytherapy of rectal cancer
Johnny Witterseh Hansen, Anders Jakobsen
Pharmacogenomics
|
November 29, 2011
Clinical implications of genetic variations in the VEGF system in relation to colorectal cancer
Torben Frøstrup Hansen, Anders Jakobsen
Gynecologic and Obstetric Investigation
|
December 18, 2004
Report of an early stopped randomized trial comparing cisplatin vs. cisplatin/ifosfamide/ 5-fluorouracil in recurrent cervical cancer
Isabelle Cadron, Anders Jakobsen, Ignace Vergote
Therapeutic Advances in Medical Oncology
|
May 8, 2023
Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors - can we RECIST? Focus on colorectal cancer
Karen-Lise Garm Spindler, Anders Jakobsen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 4, 2009
The relationship of platinum resistance and ERCC1 protein expression in epithelial ovarian cancer
Karina Dahl Steffensen, Marianne Waldstrøm, Anders Jakobsen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 2, 2017
Veliparib Monotherapy to Patients With BRCA Germ Line Mutation and Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer: A Phase I/II Study
Karina Dahl Steffensen, Parvin Adimi, Anders Jakobsen
Page
of 17
Search research articles
Search
Showing results (1-10 of 166) with videos related to
Sort By:
Page
of 17
International Journal of Radiation Oncology, Biology, Physics
|
May 7, 2013
In reply to Fekete
Anders Jakobsen
Expert Review of Anticancer Therapy
|
April 21, 2011
Combining biological agents and chemotherapy in the treatment of cholangiocarcinoma
Lars Henrik Jensen, Anders Jakobsen
Biomarkers in Medicine
|
April 7, 2020
Circulating tumor-specific DNA: a stony road to clinical utility
Caroline B Thomsen, Anders Jakobsen
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 17, 2016
Screening for circulating RAS/RAF mutations by multiplex digital PCR
Rikke Fredslund Andersen, Anders Jakobsen
Medical Physics
|
October 7, 2006
The importance of applicator design for intraluminal brachytherapy of rectal cancer
Johnny Witterseh Hansen, Anders Jakobsen
Pharmacogenomics
|
November 29, 2011
Clinical implications of genetic variations in the VEGF system in relation to colorectal cancer
Torben Frøstrup Hansen, Anders Jakobsen
Gynecologic and Obstetric Investigation
|
December 18, 2004
Report of an early stopped randomized trial comparing cisplatin vs. cisplatin/ifosfamide/ 5-fluorouracil in recurrent cervical cancer
Isabelle Cadron, Anders Jakobsen, Ignace Vergote
Therapeutic Advances in Medical Oncology
|
May 8, 2023
Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors - can we RECIST? Focus on colorectal cancer
Karen-Lise Garm Spindler, Anders Jakobsen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 4, 2009
The relationship of platinum resistance and ERCC1 protein expression in epithelial ovarian cancer
Karina Dahl Steffensen, Marianne Waldstrøm, Anders Jakobsen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 2, 2017
Veliparib Monotherapy to Patients With BRCA Germ Line Mutation and Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer: A Phase I/II Study
Karina Dahl Steffensen, Parvin Adimi, Anders Jakobsen
Page
of 17